Largest Real-Time Cardiac Monitoring Program Rolled Out in Florida: Coala Heart Monitor

Coala Life, the award-winning Swedish innovator of real-time remote cardiac monitoring solutions and the Florida-based My Cardiologist group have partnered to roll-out the most comprehensive cardiac RPM program to date using the Coala Heart Monitor in Florida.

The RPM program will include patients in need of longer-term cardiac monitoring in their daily lives using the Coala Heart Monitor for real-time analysis. The program is launched in-line with Centers for Medicare & Medicaid Services (CMS) new telehealth initiatives.

“This RPM program is unique and clinically powerful as it enables remote monitoring in real time. Coala’s solution supports our telemedicine strategy and enables efficient virtual diagnostics. We will have the ability to remotely follow thousands of patients in Southern Florida using Coala Heart Monitors,” says Qasim Ahmad, Chief Administrative Officer of the My Cardiologist group.

My Cardiologist is one of the largest private cardiology providers in Florida with 23 cardiologists at five locations across South Florida. The practices were started in 1960 by Dr. Bernard Silverstein and the My Cardiologist group was formed in 2019 following the merger of South Miami Heart Specialists and South Miami Cardiology. 

The Covid-19 pandemic has quickly transformed cardiovascular medicine with shift from traditional hands-on care to remote hands-off telemedicine to keep patients and their medical staff safe.

Coala Life is a Sweden-headquartered medical device company marketing the first fully configurable, real-time solution enabling patient-empowered remote monitoring and analysis of heart and lungs. Coala’s Microsoft Azure-based platform enables physicians to remotely access data to optimize the management of patients.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”